Celldex Therapeutics Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

20.73

0.02 (0.10%)

At close: May 02, 2025, 3:59 PM

20.66

-0.34%

After-hours: May 02, 2025, 04:05 PM EDT

Celldex Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-157.86M	-141.43M	-112.33M	-70.51M	-59.78M	-50.88M	-151.18M	-93.03M	-128.53M
Depreciation & Amortization	-12.57M	3.01M	2.9M	3.07M	3.93M	4.86M	3.8M	5.31M	4.09M
Stock-Based Compensation	34.24M	23.89M	15.61M	8.95M	3.92M	4.55M	8.08M	12.31M	15.32M
Other Working Capital	-23.53M	6.36M	-6.85M	-6.28M	-1.15M	-4.32M	-3.27M	205K	-89K
Other Non-Cash Items	16K	-6.22M	-5.79M	-1.14M	13M	-1.29M	80.2M	11.96M	1.64M
Deferred Income Tax	n/a	n/a	-227K	-227K	-1.17M	671K	-765K	-24.28M	1.01M
Change in Working Capital	-21.6M	13.46M	-3.9M	-1.05M	-299K	-4.32M	-15.37M	-12.21M	-6.56M
Operating Cash Flow	-157.78M	-107.29M	-103.73M	-60.91M	-40.4M	-46.41M	-75.23M	-99.93M	-113.04M
Capital Expenditures	n/a	-1.82M	-1.83M	-1.25M	-1.55M	-731K	-813K	-1.79M	-2.75M
Cash Acquisitions	n/a	n/a	69K	27K	55K	20K	342K	1.79M	4.59M
Purchase of Investments	-789.92M	-424.56M	-188.97M	-389.88M	-220.32M	-95.38M	-171.18M	-170.98M	-175.73M
Sales Maturities Of Investments	501.71M	320.6M	280.67M	174.95M	123.6M	113.17M	201.47M	219.24M	242.79M
Other Investing Acitivies	-1.92M	n/a	69K	27K	55K	20K	342K	-1.79M	-1.8M
Investing Cash Flow	-290.13M	-105.78M	89.94M	-216.16M	-98.22M	17.08M	29.82M	46.47M	68.91M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	9.15M	2.24M	4.08M	2.48M	434K	9K	419K	265K	536K
Financial Cash Flow	441.45M	218.46M	4.08M	272.37M	171.23M	16.26M	29.44M	51.29M	14.48M
Net Cash Flow	-6.46M	5.38M	-9.71M	-4.69M	32.6M	-13.08M	-15.98M	-2.17M	-29.65M
Free Cash Flow	-159.7M	-109.11M	-105.56M	-62.16M	-41.96M	-47.15M	-76.05M	-101.72M	-115.79M